Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Susumu Saijyo"'
Autor:
Nobuyuki Sato, Akihiko Kadota, Susumu Saijyo, Takehiko Tachibana, Syuichi Hiyamuta, Toshio Kudo, Kazuhiro Murakami, Hisaaki Saeki, Masato Nose, Ryo Takano, Syunsuke Kobayashi
Publikováno v:
Japanese Journal of Cancer Research : Gann
Twelve human monoclonal antibodies (HuMAb) were established by the fusion of (mouse x human) heteromyeloma cells with B-lymphoblastoid cells derived from the regional lymph nodes of three patients with squamous cell carcinoma of the lung. They were t
Publikováno v:
The Tohoku Journal of Experimental Medicine. 168:323-327
KUDO, T., SAEKI, H., SAIJYO, S., SATO, N., NUMASAKI, M. and TACHIBANA, T. New Strategies to Establish Human Monoclonal Antibodies. Tohoku J. Exp. Med., 1992, 168 (2), 323-327- In order to establish human monoclonal antibodies to any sort of antigens
Autor:
Hideaki Kodama, Seiki Matsuno, Toshio Kudo, Jitsuko Takahashi, Tsuyoshi Tominaga, Shinichi Takemura, Hiroshi Yoshida, Masanori Suzuki, Yu Katayose, Masao Shinoda, Hisaaki Saeki, Masahiko Ichiyama, Naoki Sakurai, Susumu Saijyo
Publikováno v:
The Tohoku journal of experimental medicine. 188(4)
In order to enhance cell mediated cytotoxicity, bispecific antibodies (BsAbs), molecules combining two or more antibodies with different antigenic specificities, have been developed as new agents for immunotherapy. Our recent studies revealed that si
Autor:
Tsuyoshi Tominaga, Natsuko Chiba, Seiki Matsuno, Masanori Suzuki, Yu Katayose, Toshio Kudo, Hisaaki Saeki, Susumu Saijyo
Publikováno v:
The Tohoku journal of experimental medicine. 178(2)
For the purpose of establishing a new in vitro model of adoptive immunotherapy, we synthesized two kinds of bispecific antibodies (BsAbs), i.e., (OK x L) BsAbs constructed with both OKT-3 (anti-CD3) and L-7-6 (anti-HCC), and (3G x L) BsAbs constructe
Autor:
Susumu Saijyo, Takao Suzuki, Taisei Muto, Yu Katayose, Seiki Matsuno, Masao Shinoda, Kenji Fukuhara, Masanori Suzuki, Toshio Kudo
Publikováno v:
The Tohoku journal of experimental medicine. 177(1)
A new human extrahepatic bile duct carcinoma cell line (TFK-1) was established from a surgically resected tumor specimen, which was histologically diagnosed as partly papillary adenocarcinoma and partly differentiated tubular adenocarcinoma. The tumo
Publikováno v:
The Tohoku journal of experimental medicine. 171(4)
KUDO, T., SAIJYO, S., SAEKI, H., SATO, N., TACHIBANA, T. and HABU, S. Production of a Human Monoclonal Antibody to a Synthetic Peptide by Active In Vivo Immunization Using a SCID Mouse Grafted with Human Lymphocytes. Tohoku J. Exp. Med., 1993, 171(4)